AMN Healthcare
381 hedge funds and large institutions have $3.05B invested in AMN Healthcare in 2023 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 140 increasing their positions, 150 reducing their positions, and 60 closing their positions.
4.58% more ownership
Funds ownership: 103.18% → 107.77% (+4.6%)
5% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 60
7% less repeat investments, than reductions
Existing positions increased: 140 | Existing positions reduced: 150
2% less funds holding
Funds holding: 389 → 381 (-8)
9% less capital invested
Capital invested by funds: $3.35B → $3.05B (-$297M)
34% less call options, than puts
Call options by funds: $13.5M | Put options by funds: $20.3M
Top Buyers
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$105M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$59.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$39M |
| 4 |
Morgan Stanley
New York
|
+$35M |
| 5 |
BlackRock
New York
|
+$27.5M |
Top Sellers
AMN Hedge Fund Activity: Q4 2023 in Review
381 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in AMN Healthcare (AMN) for Q4 2023, worth a combined $3.05B — down 8.9% from $3.35B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of AMN and 57 opened new positions — a net loss of 3 holders — while 150 trimmed existing stakes and 140 added.
The largest buyer was Boston Partners, adding an estimated $105M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $52.9M.
- 381 institutional investors held AMN Healthcare (AMN) as of Q4 2023, down from 389 in Q3 2023.
- Funds reported $3.05B of AMN Healthcare stock for Q4 2023, down 8.9% quarter-over-quarter.
- 57 funds opened new AMN Healthcare positions in Q4 2023 and 60 closed out, a net change of -3 holders.
- The largest AMN Healthcare buyer in Q4 2023 was Boston Partners, an estimated $105M added.
- The largest AMN Healthcare seller in Q4 2023 was Fuller & Thaler Asset Management, an estimated $52.9M sold.
Based on aggregated 13F filings for Q4 2023.